GenMark Diagnostics to Present at the Bank of America Merrill Lynch 2017 Health Care Conference
May 03 2017 - 5:55PM
Business Wire
GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of
automated, multiplex molecular diagnostic testing systems, will
present at the Bank of America Merrill Lynch 2017 Health Care
Conference in Las Vegas, Nevada, on Tuesday, May 16, 2017. The
presentation will be delivered by Hany Massarany, President and
Chief Executive Officer, and is scheduled to begin at 10:00 a.m.
(PT). The presentation will be made available at
http://ir.genmarkdx.com/.
ABOUT GENMARK DIAGNOSTICS
GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of
multiplex molecular diagnostic solutions designed to enhance
patient care, improve key quality metrics, and reduce the total
cost-of-care. Utilizing GenMark's proprietary eSensor® detection
technology, GenMark's eSensor XT-8® and ePlex® systems are designed
to support a broad range of molecular diagnostic tests with a
compact, easy-to-use workstation and self-contained, disposable
test cartridges. GenMark's ePlex®: The True Sample-to-Answer
Solution™ is designed to optimize laboratory efficiency and address
a broad range of infectious disease testing needs, including
respiratory, bloodstream, and gastrointestinal infections. For more
information, visit www.genmarkdx.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170503006763/en/
GenMark Diagnostics, Inc.Hany MassaranyPresident, Chief
Executive Officer760-448-4325
GenMark Diagnostics (NASDAQ:GNMK)
Historical Stock Chart
From Apr 2024 to May 2024
GenMark Diagnostics (NASDAQ:GNMK)
Historical Stock Chart
From May 2023 to May 2024
